ObjectiveThe ASTRUM-007 trial (NCT03958890) demonstrated that serplulimab plus chemotherapy administered every 2-week significantly improved progression-free and overall survival in patients with prev
This software is a highly-configurable way of modelling transitions between states, given known transition probabilities. It could therefore be used to model a disease progression and/or recovery in a
Analysis of a fibrosarcoma with ESCC case at transcriptome level Overall design: RNA-Seq of normal esophageal tissue and esophageal squamous cell carcinoma from the same individual.